Skip to Main Content
CWRU Links
Case Comprehensive Cancer Center

Case CCC Funding Opportunities

Case CCC Funding Opportunities

PILOT PROJECT GRANTS: American Cancer Society IRG Awards

Letter of Intent Deadline: Monday, April 2, 2018
Application Deadline: Monday, April 16, 2018

  • Pilot funding for CANCER-RELATED research in basic, clinical, prevention & control, behavioral, health services and epidemiology.
  • Up to $30,000 award.
  • Applications accepted for general cancer-related projects and for special interest projects in adolescent-and-young-adult cancer research.


IRG pilot project grants are intended to support independent, self-directed investigators early in their careers (usually assistant professor or equivalent). Applicants for the pilot project grants should be within 6 years of their first independent research or faculty appointment and eligible to apply for an independent national competitive research grant, but do not currently hold such a cancer-related grant.

Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application. 


John Pounardjian, MBA, Cancer Center Administration, 216.844.8326,

Request for Applications: Opportunities for Pilot Projects from VeloSano Bike to Cure


With the generous support from VeloSano Bike to Cure 2017, the Case Comprehensive Cancer Center is providing seed funding for highly innovative and impactful proposals that will generate key data for larger, nationally competitive grants. Projects aligned with at least one of six new Research Initiatives (Cancer Genomics, Cancer Immunotherapy, Brain Tumors, Drug Discovery and Development, Women’s Cancers, Community Outreach and Cancer Health Disparities) and the Center's Strategic Plan are preferred. Collaborative, multi-investigator projects are particularly encouraged.

Eligibility for funds will be restricted to PIs whose lab participated in VeloSano Bike to Cure 2017 (PI or lab members were riders, virtual riders, or volunteers). In addition, the lead PI of the application must not be eligible for CCF VeloSano funding. Co-PIs and Co-investigators are not required to have been VeloSano participants. All awardees (PI/Co-PI) are expected to participate in VeloSano 2018 and must present their research progress when requested by the Case Comprehensive Cancer Center.

Award Description:

  • Up to 7 research projects will be funded. Total funds committed to this RFA are $500,000.
  • Each research project can request a budget of up to $70,000 for one year.
  • Research projects should be completed within one year.

Funding Criteria:

  • Strong investigative teams of Case Comprehensive Cancer Center members.
  • Alignment with one or more Scientific Initiatives and the Cancer Center Strategic Plan is preferred.
  • Highly innovative and impactful projects.
  • All materials to complete the project should be in-hand or readily available. For example, tissue-based research will require an approved IRB protocol and patient cohort studies must have already recruited the cohort. Collection of new patient cohorts as the primary focus of the work is not responsive to this RFA.
  • Projects must have a high likelihood of subsequent national-level funding.
  • While investigators can be collaborators on multiple applications, only one application will be accepted per lead PI.
  • All funds for core facilities must use Case Comprehensive Cancer Center cores, when available, rather than cores at institutions outside Cleveland unless a specific justification for use of another core is submitted and approved.
  • VeloSano participation (and eligibility for this RFA) can be confirmed by contacting Case CCC pilots below.

View detailed instructions: [VeloSano-Instructions-2018]

Contact or John Pounardjian at 216.844.8326 with any questions.

Request for Proposals for Case CCC Funding for Pilot/Phase I Clinical Trials

The Case CCC is encouraging investigators to submit Letters of Intent (LOI) for Early Phase Clinical Research Support (EPCRS) funding. These in-house funds are available for the conduct of early phase clinical trials of relatively short duration. Priority will be given to trials which are developed jointly between UH and CCF with planned accrual at both institutions.

The proposals are being accepted on a rolling basis subject to availability of funds. 

Please direct any questions and/or submit LOIs to Megan Kilbane (